Role of the cop9 signalosome (csn) in cardiovascular diseases

HIGHLIGHTS

• who: Jelena Milic and collaborators from the München (KUM), Ludwig-Maximilians-University (LMU), Munich, Germany have published the Article: Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases, in the Journal: Biomolecules 2019, 9, x FOR PEER REVIEW of /2019/
• what: Inand this CRL-controlling scenario, the authors focus on the emerging role ofdruggable dysregulated CSN function in cardiovascular diseases, atherosclerosis, ischemic heart (IHD), and heart failurein(HF), as well as
• how: This study thus implies that the stability of the pro-atherogenic endothelial cell receptor ETA R and ETB R is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.